skip to main content

MALTO Meeting-in-Miniature

Previous slide Next slide
  • medicinal chemistry
  • medicinal chemistry
  • medicinal chemistry
  • medicinal chemistry
  • medicinal chemistry

The 45th Annual MALTO Medicinal Chemistry-Pharmacognosy Meeting-in-Miniature

May 23-25, 2018 at Texas A&M University, College Station, Texas

The Texas A&M University, Irma Lerma Rangel College of Pharmacy will host the 45th Annual MALTO Medicinal Chemistry-Pharmacognosy Meeting in College Station, Texas.

The MALTO research conference is a forum, the focus of which is allowing graduate, undergraduate and professional program (Pharm.D.) students and postdoctoral fellows the opportunities to present their research results and engage in discussions in an atmosphere of fellowship. The MALTO meeting also serves as a platform for the researchers/faculties from the Schools/Colleges of Pharmacy of six southern States, namely, Mississippi, Arkansas, Louisiana, Texas, Tennessee and Oklahoma to discuss and exchange ideas of drug discovery-related research in the medicinal chemistry and pharmacognosy disciplines.

The A. Nelson Voldeng keynote speaker for this year's MALTO meeting will be Dr. Carol Fierke, Professor of Chemistry. Dr. Fierke is also the Provost and Vice President of the Texas A&M University.

We are excited to announce that this year’s meeting will have another outstanding speaker with extensive knowledge of pharmaceutical research and education to deliver a plenary lecture on the topic: Crossing Over: A Drug Discovery Perspective from Pharma and Academia.

Dr. Magid Abou-Gharbia, formerly the Senior Vice President & Head of Chemical & Screening Sciences at Wyeth Pharmaceuticals.

Dr. Abou-Gharbia currently is the Director of the Moulder Center for Drug Discovery and Associate Dean of Research of the School of Pharmacy, Temple University. He has spent 26 years as the head of drug discovery at Wyeth Pharmaceuticals Corp., where he led the discovery of nine marketed drugs, which include the anticancer drugs Mylotarg, Torisel, Bosulif and Neratinib, and other drugs for the treatment of osteoporosis (Combriza), depression (Effexor and Pristique), insomnia (Sonata), and bacterial infections (Tygacil). Dr. Abou-Gharbia is the holder of more than 350 drug discovery patents worldwide, he was the recipient of the American Chemical Society’s 2014 Heroes of Chemistry award for his team’s discovery of the antidepressant drug Effexor. Dr. Abou-Gharbia is a highly esteemed and internationally renowned scientist whose many outstanding contributions in pharmaceutical research and innovations has benefited over 25 million patients worldwide.

The MALTO organization was founded in 1973. 


Suggestions for Students

Visit College Station

Facebook Twitter RSS YouTube Instagram Flickr